|
National Stock Number(NSN): 6505-01-282-1824 (6505012821824, 012821824)
| NIIN: |
01-282-1824 |
Item Name: |
MITOXANTRONE HYDROCHLORIDE CONCENTRATE FOR INJECTION |
INC: |
45163
|
| FSC: |
6505
|
Assignment Date: |
Jul-09-1988 |
CRIT: |
X |
IIG: |
45163 |
| ISC: |
2 |
Date Standardized: |
Sep-06-1989 |
HMIC: |
P |
DODIC: |
|
| NSC: |
8 |
Cancellation Date: |
Apr-30-2010 |
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
9-0534 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00005-9393-72 |
3M726
|
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00205-9393-72 |
3M726
|
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV |
H |
5 |
9 |
4 |
ZZ |
|
B |
|
|
|
|
|
NDC58406-0640-05 |
3M726
|
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
NOVANTRONE |
3M726
|
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
H |
|
M |
U |
1 |
A |
$851.09 |
VI |
|
C2201X- |
Oct-01-2000 |
H |
| DF |
S9M |
H |
|
M |
U |
1 |
F |
$851.09 |
VI |
|
------- |
Oct-01-2000 |
H |
| DN |
SMS |
Y |
|
M |
U |
1 |
N |
$851.09 |
VI |
|
9L----- |
Nov-01-2007 |
H |
| DS |
SMS |
Y |
|
M |
U |
1 |
D |
$851.09 |
VI |
|
------- |
Dec-01-2000 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 12.5ML |
000 |
|
|
|
| DA |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 12.5ML |
000 |
|
|
|
| DF |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 12.5ML |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 12.5ML |
000 |
|
|
|
| DS |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AJCN |
PROTECTIVE STORAGE FEATURE |
ANTINEOPLASTIC DRUG |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
2.000 MG MITOXANTRONE EQUIVALENT PER ML |
| CBBL |
FEATURES PROVIDED |
STERILE |
| CQCT |
PRIMARY CONTAINER TYPE |
VIAL, SINGLE DOSE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
12.500 MILLILITERS |
| ECWT |
EXTERIOR CONTAINER WEIGHT |
8.00 POUNDS |
| EXME |
EXTERIOR CONTAINER CUBIC MEASURE |
0.50 CUBIC FEET |
| EXQT |
EXTERIOR CONTAINER QUANTITY |
96 |
| SUCB |
UNIT OF ISSUE CUBE |
0.005 CUBIC FEET |
| SUPP |
SUPPLEMENTARY FEATURES |
ANTINEOPLASTIC (CHEMOTHERAPY) DRUG |
| SUWT |
UNIT OF ISSUE WEIGHT |
0.08 POUNDS |
|